Cigna Group will eliminate prescription drug rebates in many of its commercial health plans in 2027, a practice that has ...
Intellia Therapeutics said it is pausing two late-stage CRISPR gene-editing trials after a patient in one study was ...
Pharmacy closures are accelerating, leaving 45 million Americans in pharmacy deserts. Here's how to fix the problem.
China rivalry heats up, Chinese drugmakers are striking major deals with their global counterparts — including some in the ...
A trade group representing generic drugmakers is seeking an injunction to thwart a provision of a new Connecticut law that ...
Novartis is buying Avidity Biosciences for $12 billion, picking up RNA-based medicines for neuromuscular diseases as it seeks ...
In the past two years, patients with dementia and their families have begun to speak about hope in new ways, writes new STAT columnist Jason Karlawish.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback